Eli Lilly’s Orforglipron Clears First Late-Stage Trial, Boosts Weight Loss Hopes April 17, 2025 Indianapolis, IN – Eli Lilly’s experimental oral weight reduction tablet, orforglipron, met its objectives within the first of seven late-stage trials, serving to Sort 2 diabetes sufferers lose 7.9% of physique weight (16 kilos) and decrease blood sugar over 40 weeks, … Read more
Trump Indicators Pharmaceutical Tariffs Are Coming, But Shares Rise in Defiance April 9, 2025 – Washington, D.C. – President Donald Trump doubled down on his commerce warfare rhetoric Tuesday night time, declaring at a Nationwide Republican Congressional Committee dinner that “main” tariffs on pharmaceutical imports are imminent, a transfer he insists will “carry drug manufacturing … Read more
Eli Lilly to Unveil Trial Data for Oral Weight Loss Drug Orforglipron [City, Date] – Pharmaceutical giant Eli Lilly is set to release highly anticipated clinical trial data for its experimental oral weight loss drug, orforglipron, as the race to dominate the booming obesity treatment market intensifies. The upcoming data could position the company as … Read more